From With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy:

Tioma Therapeutics
Tioma Therapeutics

Tioma Therapeutics has a portfolio of anti-CD47 antibodies, which create an immune response to cancer cells. Photo courtesy Tioma: https://www.tiomatherapeutics.com/science/cd47-biology/